Departamento
MEDICINA
Publicaciones (321) Publicaciones en las que ha participado algún/a investigador/a
2018
-
CD34 + Cell Selection versus Reduced-Intensity Conditioning and Unmodified Grafts for Allogeneic Hematopoietic Cell Transplantation in Patients Age >50 Years with Acute Myelogenous Leukemia and Myelodysplastic Syndrome
Biology of Blood and Marrow Transplantation, Vol. 24, Núm. 5, pp. 964-972
-
Characterization of CD34 + hematopoietic cells in systemic mastocytosis: Potential role in disease dissemination
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 73, Núm. 6, pp. 1294-1304
-
Highly sensitive MYD88 l265p mutation detection by droplet digital polymerase chain reaction in waldenström macroglobulinemia
Haematologica, Vol. 103, Núm. 6, pp. 1029-1037
-
A Perspective on Proteomics of Infectious Diseases
Proteomics - Clinical Applications, Vol. 12, Núm. 4
-
A body shape index and vascular structure and function in Spanish adults (MARK study) A cross-sectional study
Medicine (United States), Vol. 97, Núm. 47
-
A community approach to mortality prediction in sepsis via gene expression analysis
Nature Communications, Vol. 9, Núm. 1
-
A cost-effectiveness analysis of denosumab for the prevention of skeletal-related events in patients with multiple myeloma in the United States of America
Journal of Medical Economics, Vol. 21, Núm. 5, pp. 525-536
-
A cross-sectional study of the impact of educational information on topical photoprotection habits in medical students
Semergen, Vol. 44, Núm. 6, pp. 420-429
-
A multicentre randomized pilot trial on the effectiveness of different levels of cooling in comatose survivors of out-of-hospital cardiac arrest: the FROST-I trial
Intensive Care Medicine, Vol. 44, Núm. 11, pp. 1807-1815
-
A multiple myeloma classification system that associates normal B-cell subset phenotypes with prognosis
Blood Advances, Vol. 2, Núm. 18, pp. 2400-2411
-
A novel FAS mutation with variable expressivity in a family with unicentric and idiopathic multicentric Castleman disease
Blood Advances, Vol. 2, Núm. 21, pp. 2959-2963
-
A novel nano-immunoassay method for quantification of proteins from CD138-purified myeloma cells: Biological and clinical utility
Haematologica, Vol. 103, Núm. 5, pp. 880-889
-
A personalized intervention to prevent depression in primary care: Cost-effectiveness study nested into a clustered randomized trial
BMC Medicine, Vol. 16, Núm. 1
-
A phase 2 trial of neoadjuvant metformin in combination with trastuzumab and chemotherapy in women with early HER2-positive breast cancer: The METTEN study
Oncotarget, Vol. 9, Núm. 86, pp. 35687-35704
-
A phase I/II dose-escalation study investigating all-oral ixazomib-melphalanprednisone induction followed by single-agent ixazomib maintenance in transplant-ineligible newly diagnosed multiple myeloma
Haematologica, Vol. 103, Núm. 9, pp. 1518-1526
-
A phase I–II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia
Annals of Hematology, Vol. 97, Núm. 5, pp. 763-772
-
A question of class: Treatment options for patients with relapsed and/or refractory multiple myeloma
Critical Reviews in Oncology/Hematology, Vol. 121, pp. 74-89
-
A retrospective study of pregnancy-associated atypical hemolytic uremic syndrome
Kidney International, Vol. 93, Núm. 2, pp. 450-459
-
A safety profile of medications used to treat Waldenström’s macroglobulinemia
Expert Opinion on Drug Safety, Vol. 17, Núm. 6, pp. 609-621
-
A survey of perceptions, attitudes, knowledge and practices of medical oncologists about cancer pain management in Spain
Clinical and Translational Oncology, Vol. 20, Núm. 8, pp. 1061-1071